MINNEAPOLIS, July 17, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (“Inspire”) (NYSE:INSP), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the second quarter 2018 after the close of trading on Tuesday, August 7, 2018. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. ET to discuss the financial results and recent business developments.
To listen to a live webcast, please visit the Investors section of the Inspire website at: www.inspiresleep.com. The webcast replay will be available on the Inspire website for two weeks following the completion of the call.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire Medical Systems’ proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. For additional information about Inspire, please visit www.inspiresleep.com.
|
Inspire Investor and Media Contact
|
| Bob Yedid |
| LifeSci Advisors |
|
[email protected]
|
| 646-597-6989 |
Source: Inspire Medical Systems, Inc.